Thyrocare Technologies Ltd
Healthcare
COVID-19 tests to be small part of biz, won't delight investors: Thyrocare founder
Last month, the Indian government allowed some accredited private labs to test coronavirus samples. The move was seen as a ......
Healthcare
Nalanda sniffs opportunity in coronavirus outbreak, makes first-ever healthcare bet
Nalanda Capital, an India-focused private equity-style investor in public equities, has bought a minority stake in a diagnostics...
Healthcare
Coronavirus: Pathology chains wait on the sidelines, device makers gear up
The number of confirmed coronavirus cases (COVID-19), which was declared a pandemic by the World Health Organization (WHO) last...
Healthcare
Sector Watch: How PE-backed regional pathology chains stack up versus national peers
A few months after Thyrocare Technologies Ltd made a spectacular debut on stock exchanges, its founder A Velumani predicted that...
Healthcare
How diagnostics companies can drive efficiency as price caps loom
With the spectre of the National Essential Diagnostics List and price caps looming over diagnostics industry, margins may come under ......
Healthcare
Diagnostics firms shouldn't fear price controls: Panellists at VCCircle summit
Diagnostics companies must focus on providing good-quality services and building sustainable business models instead of worrying...
Healthcare
Carlyle-backed Metropolis acquires four pathology labs
Pathology chain Metropolis Healthcare Ltd, which went public earlier this year, said it has acquired four labs to strengthen its...
Healthcare
Metropolis Healthcare gains on trading debut after $174-mn IPO
Pathology chain owner Metropolis Healthcare Ltd made a strong debut on the stock markets on Monday with its shares listing ......
Healthcare
Carlyle-backed Metropolis' IPO subscribed almost six times on final day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) was subscribed almost six times on the third...
Healthcare
Carlyle-backed Metropolis Healthcare's IPO nears halfway mark on second day
Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) reached nearly halfway mark on its second...
